Synthetic Genomics Inc. and ADM Announce Omega-3 DHA Strategic Partnership

LA JOLLA, Calif. and DECATUR, Ill, May 19, 2014 – Synthetic Genomics Inc. (SGI), a privately held company developing and commercializing genomic driven advancements in a variety of industries, and Archer Daniels Midland Company (NYSE: ADM) announced today that the two companies have entered into a long-term agreement to commercialize Omega-3 Docosahexaenoic Acid (DHA) from algae. As part of the agreement, Omega-3 DHA will be produced and marketed throughout the world by ADM’s Foods & Wellness and Animal Nutrition groups. Financial details of the deal were not disclosed.

DHA is a long-chain omega-3 fatty acid that has been studied for its role in brain, heart and eye health. While it is typically found in fish and seafood products, extracting DHA directly from algae grown in fermentation tanks yields a highly purified form of DHA, which can then be used as a dietary supplement for humans and in animal feed.

“We are pleased to be working with ADM, a global leader in human and animal health and nutrition,” said J. Craig Venter, Founder and CEO, SGI. “This agreement is a major accomplishment for SGI as it represents commercial validation of our science and technology. We are eager to continue to work with ADM to develop other unique and nutritionally sound food and nutraceutical ingredients.”

“This partnership is an important example of ADM’s ongoing efforts to enhance returns by strengthening our portfolio of higher-margin products,” said Greg Dodson, general manager, ADM Foods & Wellness. “There is significant demand for Omega-3 DHA products. We are impressed with the leading edge technologies that SGI uses to quickly turn commercial opportunities into realities, and we look forward to working with them to use those capabilities to further enhance our current portfolio of nutritional ingredients.”

“The ADM partnership with SGI will prove beneficial for both companies by capitalizing on the strengths of SGI’s technologies and know-how, while using ADM’s significant scale and production capabilities to commercialize important products demanded by our customers,” said Brent Fenton, president, ADM Animal Nutrition. “The end result will be an improved animal nutrition portfolio, which will deliver value both to our customers and our shareholders.”

“We are excited to have this partnership with ADM that will allow them to provide a real alternative to what had been a very short list of non-fish derived DHA ingredients,” said Jon Getzinger, senior vice president at SGI. “Having a real choice in the market will provide manufacturers the opportunity for broader inclusion of this essential nutrient in food, beverage, nutraceutical and animal feed applications.”

The program will be done by SGI’s Genovia Bio business unit, leading producers of algal bio-based food, chemical, and fuel products. The team designs, develops, manufactures and enables others to manufacture nutritional and personal care ingredients, chemicals and fuels through low-cost, sustainable bio-based production methods from renewable feedstocks, including sugar, and carbon dioxide and sunlight. The business unit also licenses technology to strategic partners to manufacture higher-volume products.

Genovia Bio has labs within the SGI offices in La Jolla, California and has a research and development and phototrophic algae production facility in Calipatria, California near the Salton Sea.

About Synthetic Genomics Inc. (SGI)

SGI is a privately-held company dedicated to developing and commercializing genomic-driven solutions to address a wide range of global challenges. The company is focused on several key commercialization programs including: developing new synthetic DNA products and technologies through its subsidiary, SGI-DNA; algae biofuels and new and improved food and nutritional products through its subsidiary Genovia Bio; and synthetically-derived vaccine development through Synthetic Genomic Vaccines Inc. (SGVI), a business unit co-founded with the J. Craig Venter Institute. The company is also developing clean water technologies using microbial fuel cells and is developing sustainable agricultural products through AgraCast, a company co-founded with Plenus S.A. de C.V. For more information go to www.syntheticgenomics.com.

About ADM Foods & Wellness

ADM’s Foods & Wellness group offers a range of innovative specialty ingredients and products for the beverage, meat, snack, bakery, cerdodeal, wellness and personal care markets. As a global market leader in food-grade proteins, ADM’s Foods & Wellness group also markets numerous health and nutrition products, lecithin, acidulants, hydrocolloids and polyols.

About ADM Animal Nutrition

ADM Animal Nutrition is a leading manufacturing, nutrition and marketing company, which offers a wide range of innovative products for the animal nutrition market. Known as a global leader in amino acids, ADM Animal Nutrition also offers consistent, high-quality feed products, supplements, premixes, custom ingredient blends and specialty feed ingredients designed to provide leading-edge solutions, enabling our customers to meet and optimize animal health and nutrition goals.

About ADM

For more than a century, the people of Archer Daniels Midland Company (NYSE: ADM) have transformed crops into products that serve vital needs. Today, 31,000 ADM employees around the globe convert oilseeds, corn, wheat and cocoa into products for food, animal feed, industrial and energy uses. With more than 270 processing plants, 470 crop procurement facilities, and the world’s premier crop transportation network, ADM helps connect the harvest to the home in more than 140 countries. For more information about ADM and its products, visit www.adm.com.

Media Contact for SGI

Heather Kowalski
858-361-0466
hkowalski@syntheticgenomics.com

Media Relations for ADM

Jackie Anderson
217-424-5413
media@adm.com